Bayer: Offer Period for Algeta Shares Runs From Jan 20-Feb 24
Bayer: Offer Period for Algeta Shares Runs from Jan 20-Feb 24
Filed under: Houston Drug Treatment
A successful offer would give Bayer full control of potential blockbuster cancer treatment Xofigo, which the two companies have developed together since 2009. Bayer estimates the drug could reach peak sales of more than EUR5.5 billion a year. Xofigo …
Read more on Wall Street Journal
Tuesday's Sports Transactions
Filed under: Houston Drug Treatment
COMMISSIONER'S OFFICE — Suspended Milwaukee LHP Will West 100 games after testing positive for an amphetamine, in violation of the Minor League Drug Prevention and Treatment Program, as well as a third positive test for a drug of abuse. … HOUSTON …
Read more on San Francisco Chronicle
Survey: 1 in 10 NH adolescents use marijuana
Filed under: Houston Drug Treatment
"This is a disturbing finding," said Joe Harding, director of the department's Bureau of Drug and Alcohol Services. "It is an alarming rate and is well above the U.S. average of 7.6 percent of 12-10-17-year-olds nationally reporting marijuana use.
Read more on Houston Chronicle
Vast majority of stroke patients get treatment in Corpus Christi
Filed under: Houston Drug Treatment
That medicine is the only treatment approved by the U.S. Food and Drug Administration to treat a stroke caused by blood vessel blockage, the kind that suffered. It's the most common kind of stroke, accounting for about 87 percent of cases. … of …
Read more on Corpus Christi Caller Times